Home > Qtrly Results > BLISS GVS PHARMA

BLISS GVS PHARMA
Quarterly Results Analysis [Dec2023]

BLISS GVS PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Quarterly Results

Consolidated Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
UnAudited
Dec2022
UnAudited
Sep2022
Audited
Jun2022
UnAudited
Mar2022
UnAudited
Revenues ₹201 Cr ₹212 Cr ₹160 Cr ₹185 Cr ₹206 Cr ₹172 Cr ₹189 Cr ₹167 Cr
Expenses ₹157 Cr ₹158 Cr ₹135 Cr ₹179 Cr ₹158 Cr ₹148 Cr ₹150 Cr ₹147 Cr
Operating Income ₹44 Cr ₹54 Cr ₹24 Cr ₹6 Cr ₹48 Cr ₹25 Cr ₹39 Cr ₹20 Cr
Other Income ₹5 Cr ₹13 Cr ₹5 Cr ₹3 Cr ₹6 Cr ₹2 Cr ₹7 Cr ₹12 Cr
Interest ₹2 Cr ₹1 Cr ₹1 Cr ₹5 Cr ₹1 Cr ₹2 Cr ₹2 Cr ₹2 Cr
Depreciation ₹7 Cr ₹6 Cr ₹6 Cr ₹5 Cr ₹5 Cr ₹5 Cr ₹5 Cr ₹4 Cr
Profit Before Tax ₹40 Cr ₹59 Cr ₹22 Cr ₹-1 Cr ₹47 Cr ₹20 Cr ₹39 Cr ₹26 Cr
Profit After Tax ₹29 Cr ₹43 Cr ₹14 Cr ₹3 Cr ₹30 Cr ₹16 Cr ₹27 Cr ₹23 Cr
EPS ₹2.64 ₹4.05 ₹1.41 ₹0.32 ₹2.68 ₹1.33 ₹2.48 ₹1.89
Industry Peers & Returns1W1M1Y
BLISS GVS PHARMA 6.1% 5.8% 50.3%
SUN PHARMACEUTICAL INDUSTRIES -2.3% -6.5% 55.3%
CIPLA 4.1% -4.8% 55.6%
DR REDDYS LABORATORIES 4% 0.8% 29.4%
ZYDUS LIFESCIENCES -1.2% -5.2% 83.9%
DIVIS LABORATORIES 7.8% 17.4% 20.3%
MANKIND PHARMA 1.3% 7% NA
TORRENT PHARMACEUTICALS 3.9% 5.1% 66.1%
LUPIN 0.6% 0.5% 127.2%

BLISS GVS PHARMA Quarterly Revenues

Revenues
Q-o-Q

-5.27 %

Y-o-Y

-2.43 %

Quarters Revenues % Change
Dec2023 ₹201 Cr
-5.27
Sep2023 ₹212 Cr
32.82
Jun2023 ₹160 Cr
-13.67
Mar2023 ₹185 Cr
-10.18
Dec2022 ₹206 Cr
19.30
Sep2022 ₹172 Cr
-8.60
Jun2022 ₹189 Cr
12.93
Mar2022 ₹167 Cr -

BLISS GVS PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

-19.63 %

Y-o-Y

-8.38 %

Quarters Operating Profit % Change
Dec2023 ₹44 Cr
-19.63
Sep2023 ₹54 Cr
124.54
Jun2023 ₹24 Cr
287.97
Mar2023 ₹6 Cr
-86.91
Dec2022 ₹48 Cr
94.28
Sep2022 ₹25 Cr
-36.82
Jun2022 ₹39 Cr
92.67
Mar2022 ₹20 Cr -
Operating Margins
Q-o-Q

-15.16 %

Y-o-Y

-6.08 %

Quarters Operating Margin% % Change
Dec2023 21.77%
-15.16
Sep2023 25.66%
69.04
Jun2023 15.18%
349.11
Mar2023 3.38%
-85.42
Dec2022 23.18%
62.90
Sep2022 14.23%
-30.89
Jun2022 20.59%
70.59
Mar2022 12.07% -

BLISS GVS PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-32.46 %

Y-o-Y

-2.41 %

Quarters Profit After Tax % Change
Dec2023 ₹29 Cr
-32.46
Sep2023 ₹43 Cr
199.44
Jun2023 ₹14 Cr
314.62
Mar2023 ₹3 Cr
-88.36
Dec2022 ₹30 Cr
86.16
Sep2022 ₹16 Cr
-41.76
Jun2022 ₹27 Cr
17.10
Mar2022 ₹23 Cr -
PAT Margins
Q-o-Q

-28.74 %

Y-o-Y

0.00 %

Quarters PAT Margin(%) % Change
Dec2023 14.48 %
-28.74
Sep2023 20.32 %
125.53
Jun2023 9.01 %
379.26
Mar2023 1.88 %
-87.02
Dec2022 14.48 %
56.03
Sep2022 9.28 %
-36.26
Jun2022 14.56 %
3.63
Mar2022 14.05 % -

BLISS GVS PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-34.81 %

Y-o-Y

-1.49 %

Quarters EPS % Change
Dec2023 ₹2.64
-34.81
Sep2023 ₹4.05
187.23
Jun2023 ₹1.41
340.63
Mar2023 ₹0.32
-88.06
Dec2022 ₹2.68
101.50
Sep2022 ₹1.33
-46.37
Jun2022 ₹2.48
31.22
Mar2022 ₹1.89 -

You may also like the below Video Courses